Status:
COMPLETED
Increasing Cervical Cancer Screening Uptake Among Emergency Department Patients
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cervical Cancer
Eligibility:
FEMALE
21-65 years
Phase:
NA
Brief Summary
Invasive cervical cancer is preventable with adequate screening but screening rates are considerably below national goals. Emergency departments care for a disproportionate number of women who are not...
Detailed Description
Cervical cancer (CC) is preventable. Screening for CC aims to identify treatable lesions prior to the development of invasive CC which, without screening, is often first detected at a stage when comfo...
Eligibility Criteria
Inclusion
- female
- age 21 - 65 years
- demonstrating decisional capacity to consent to participate
Exclusion
- past hysterectomy with cervical removal
- the absence of a cervix (i.e. in patient that is a transwoman
- known infection with HIV (as screening recommendations for women with HIV differ from the general population)
- inability to consent (e.g., lacking decisional capacity, intoxicated, or in distress)
- non-English/Spanish/American Sign Language (ASL) speaking (Spanish and ASL interpreter services are available 24/7 in our system and will be paid for through grant funds)
Key Trial Info
Start Date :
December 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
1116 Patients enrolled
Trial Details
Trial ID
NCT04374760
Start Date
December 3 2020
End Date
January 31 2024
Last Update
April 24 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nicolas Noyes Community Hospital
Dansville, New York, United States, 14437
2
Strong Memorial Hospital Emergency Department
Rochester, New York, United States, 14642